PI
TARO

Putnam Investments’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Putnam Investments’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-9,236
Closed -$1.04M – 1190
2017
Q3 		$1.04M Buy
9,236
+1,149
+14% +$125K ﹤0.01% 906
2017
Q2 		$906K Sell
8,087
-175
-2% -$19.8K ﹤0.01% 914
2017
Q1 		$963K Buy
8,262
+15
+0.2% +$1.66K ﹤0.01% 1006
2016
Q4 		$868K Sell
8,247
-168
-2% -$17.6K ﹤0.01% 1035
2016
Q3 		$930K Buy
8,415
+6,017
+251% +$797K ﹤0.01% 1031
2016
Q2 		$349K Buy
+2,398
New +$340K ﹤0.01% 1243

Other funds holding TARO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
MICM
Matthews International Capital Management San Francisco, California $292M AUM 75.01% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
FL
Fort LP Chevy Chase, Maryland $39.6M AUM 37.11% 1-Year Est. Return

Putnam Investments's TARO Position: Q4 2017 in Review

Putnam Investments sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q4 2017, closing a stake of 9,236 shares — an estimated $1.04M sold.

Putnam Investments first reported a position in TARO in Q2 2016 and held it in 6 quarters. The position peaked at $1.04M in Q3 2017. 127 funds tracked by Wall St. Rank hold TARO as of Q4 2017.

  • Putnam Investments reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q4 2017 after selling out during the quarter.
  • Putnam Investments sold 9,236 Taro Pharmaceutical Industries Ltd. shares in Q4 2017, an estimated $1.04M.
  • Putnam Investments first reported a position in Taro Pharmaceutical Industries Ltd. in Q2 2016 and held it in 6 quarters.
  • Putnam Investments's Taro Pharmaceutical Industries Ltd. position peaked at $1.04M in Q3 2017.
  • 127 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q4 2017.

Based on Putnam Investments's 13F filing for Q4 2017, filed 14 Feb 2018.